I’m often asked by clients to help them build a business case to secure the budgets and resources required for effective, pro-active reputation management. This is an executive summary that brings together key pieces of research that each look at the benefits of investing in corporate reputation management, much of which informs the work that […]
Read More ›Pharma RepTrak 2016 – a critique This week saw the publication of the latest data on pharma reputation amongst the general public from both Reputation Institute (RI) and Edelman. It is concerning to see that their findings are contradictory. What is a pharma reputation manager to make of this? The studies raise questions around what […]
Read More ›In a thoroughly good BBC interview led by Hugh Edwards, President Obama very eloquently and rather forcefully put forward his view that the UK should remain in the EU. His reasoning being that the UK would struggle to get a trade deal with the USA outside of the EU. In an earlier interview he also […]
Read More ›